Storage and handling
Other information read all warnings and directions before use. Keep carton. store at 20-25°C (68-77°F) avoid excessive heat above 40°C (104°F)
Other information read all warnings and directions before use. Keep carton. store at 20-25°C (68-77°F) avoid excessive heat above 40°C (104°F)
Drug Facts
Uses
Warnings
This product contains acetaminophen. Severe liver damage may occur if you take:
Acetaminophen allergy alert: may cause severe skin reactions. Symptoms may include:
If skin reaction occurs, stop use and seek medical help right away.
NSAID allergy alert: ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin.
Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
| adults and children 12 years and over |
|
| children under 12 years |
|
Other information
Inactive ingredients
carnauba wax, colloidal silicon dioxide, croscarmellose sodium, ferric oxides, glyceryl dibehenate, hypromellose, pharmaceutical ink, polydextrose, polyethylene glycol, pregelatinized starch, titanium dioxide
Questions or comments?
call weekdays 9 AM to 5 PM at 1-800-88-ADVIL
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67751-211-01 | 2024-04-15 | C162847 | 48780-1 | 1030e365-60c0-111a-e063-dadaa90a10e2 | Advil Dual Action with Acetaminophen |
| 67751-211-02 | 2024-04-15 | C162847 | 48780-1 | 1030e365-60c0-111a-e063-dadaa90a10e2 | Advil Dual Action with Acetaminophen |
| 67751-211-01 | 2024-01-30 | C162847 | 48780-1 | 1030e365-60c0-111a-e063-dadaa90a10e2 | Advil Dual Action with Acetaminophen |
| 67751-211-02 | 2024-01-30 | C162847 | 48780-1 | 1030e365-60c0-111a-e063-dadaa90a10e2 | Advil Dual Action with Acetaminophen |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67751-211-01 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 3 | |
| 67751-211-01 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 67751-211-02 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 67751-211-02 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67751-211 | ADVIL DUAL ACTION WITH ACETAMINOPHEN (IBUPROFEN, ACETAMINOPHEN) TABLET, FILM COATED [NAVAJO MANUFACTURING COMPANY INC.] | 3 | Current NDC, Legacy NDC, 4 package rows | 20240417_bd0d7812-4e42-b533-e053-2995a90ae1f9.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0573-0147-09 | EA - Each | 0573-0147 | 594ad440-0e6d-4409-8126-29af7eeb6c64 | 1 | 2024-12-10 |
| 0573-0147-86 | EA - Each | 0573-0147 | 203f8a8a-d4e6-4f58-8405-8a84dc3a9040 | 1 | 2024-12-10 |
| 0573-0147-94 | EA - Each | 0573-0147 | 0600a503-4311-4e1a-9f4d-3fe895b9ae3b | 1 | 2021-10-08 |
| 0573-0147-95 | EA - Each | 0573-0147 | 8987ba23-fe04-4d0a-9a96-921186f6c1e9 | 1 | 2024-12-10 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 67751-211 | 67751-211-01, 67751-211-02 |
| 0573-0147 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CARNAUBA WAX | R12CBM0EIZ | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| FERRIC OXIDE RED | 1K09F3G675 | IACT |
| GLYCERYL DIBEHENATE | R8WTH25YS2 | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| POLYDEXTROSE | VH2XOU12IE | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| IBUPROFEN | WK2XYI10QM | ACTIB |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | ACETAMINOPHEN; IBUPROFEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 |
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | c0c555d07b60… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N211733-001 | ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | TABLET / ORAL | RLD, RS | 2020-02-28 | a50c72e98297… |
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | 8072bd15b7f6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N211733-001 | 11918693 | 2041-07-09 | Drug product | 2024-03-26 | a50c72e98297… |
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N211733-001 | NP | 2023-02-28 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N211733-001 | NP | 2023-02-28 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N211733-001 | NP | 2023-02-28 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | N211733-001 | NP | 2023-02-28 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N211733-001 | NP | 2023-02-28 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N211733-001 | NP | 2023-02-28 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N211733-001 | NP | 2023-02-28 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N211733-001 | NP | 2023-02-28 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N211733-001 | NP | 2023-02-28 | c0c555d07b60… |
| 2023-12-20 04:57 UTC | 2023-12 | N211733-001 | NP | 2023-02-28 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N211733-001 | NP | 2023-02-28 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N211733-001 | NP | 2023-02-28 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N211733-001 | NP | 2023-02-28 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N211733-001 | NP | 2023-02-28 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N211733-001 | NP | 2023-02-28 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N211733-001 | NP | 2023-02-28 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N211733-001 | NP | 2023-02-28 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N211733-001 | NP | 2023-02-28 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N211733-001 | NP | 2023-02-28 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N211733-001 | NP | 2023-02-28 | cb3db0bc1861… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADVIL DUAL ACTION WITH ACETAMINOPHEN | IBUPROFEN, ACETAMINOPHEN | Haleon US Holdings LLC | f5ea858e-76d9-4777-b3dc-5d614f66d485 | 2025-04-21 | Warnings | 0573-0147 |
| ADVIL DUAL ACTION WITH ACETAMINOPHEN | IBUPROFEN, ACETAMINOPHEN | Navajo Manufacturing Company Inc. | bd0d7812-4e42-b533-e053-2995a90ae1f9 | 2024-04-15 | Warnings | 67751-211-01 67751-211-02 67751-211 67751021102 67751021101 16264d4c-f111-10c1-e063-6294a90a9beb bd0d7812-4e42-b533-e053-2995a90ae1f9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.